You are viewing: Rest Of Europe Medical Device Contract Manufacturing Market analysis

The Rest Of Europe Medical Device Contract Manufacturing Market was valued at $773.5 Million in 2025 and projected to reach to $1262.6 Million by 2030, representing a compound annual growth rate of 10.3%. Rest Of Europe's medical device contract manufacturing sector is positioned for sustained expansion, driven by increasing outsourcing adoption among global medical device manufacturers seeking cost-effective yet quality-assured production.

Rest Of Europe Medical Device Contract Manufacturing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Medical Device Contract Manufacturing Market Trends and Insights

  • This 10.3% compound annual growth rate reflects Rest Of Europe's strengthening position as a critical hub for outsourced medical device production, driven by regulatory expertise, advanced manufacturing capabilities, and proximity to major European markets.
  • Rest Of Europe benefits from a skilled workforce and established supply chain networks that support both established and emerging device manufacturers seeking reliable contract manufacturing partners. The forecast period through 2030 demonstrates Rest Of Europe's increasing attractiveness for medical device contract manufacturing investments.
  • Rest Of Europe's growth trajectory outpaces many global markets, supported by rising demand for specialized manufacturing services, regulatory compliance expertise, and cost-competitive production capabilities.
  • Rest Of Europe continues to attract multinational device manufacturers and emerging companies seeking to establish or expand manufacturing operations within the region, positioning the market for sustained expansion and consolidation among leading contract manufacturers..

Key Market Statistics

  • CAGR (2025-2030) 10.3% CAGR
  • Market Size, 2025 ~USD 773.5 Million
  • Forecast, 2030 ~USD 1262.6 Million
  • Country Rest Of Europe

Rest Of Europe Medical Device Contract Manufacturing Market Overview

Strong Market Valuation :

Rest Of Europe's medical device contract manufacturing market is valued at $773.5 million in 2025, demonstrating significant economic activity and investment in the region's outsourced production capabilities.

Robust Growth Trajectory :

With a 10.3% CAGR through 2030, Rest Of Europe is expanding faster than many mature markets, driven by increasing demand for specialized manufacturing services and regulatory compliance expertise.

Regulatory Excellence Hub :

Rest Of Europe's manufacturers benefit from stringent EU regulatory frameworks and ISO certifications, making them preferred partners for companies requiring high-quality, compliant medical device production.

Projected Market Expansion :

The market is forecast to reach $1,262.6 million by 2030, representing a $489.1 million increase that reflects growing outsourcing adoption and Rest Of Europe's competitive manufacturing advantages.

Rest Of Europe Medical Device Contract Manufacturing Market Dynamics

  • The region's advanced manufacturing infrastructure, skilled workforce, and proximity to major European markets create competitive advantages that attract both established and emerging device companies.
  • Regulatory harmonization within the EU framework further strengthens Rest Of Europe's appeal as a reliable manufacturing partner. Looking ahead to 2030, Rest Of Europe will likely see consolidation among contract manufacturers, increased investment in automation and digital technologies, and growing specialization in high-complexity device categories.
  • The region's ability to balance cost efficiency with stringent quality standards positions it favorably against global competitors, supporting the projected 10.3% CAGR and market expansion to $1,262.6 million..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Europe's medical device contract manufacturing market is valued at $773.5 million in 2025 and will reach $1,262.6 million by 2030, representing a 10.3% CAGR.
    • Rest Of Europe's regulatory expertise and compliance infrastructure make it an attractive destination for device manufacturers requiring EU-aligned manufacturing operations.
    • Rest Of Europe's skilled workforce and established supply chain networks provide competitive advantages for contract manufacturers serving regional and global markets.
    • Rest Of Europe's market growth is driven by increasing outsourcing trends, demand for specialized manufacturing capabilities, and expansion of medical device production capacity.

    Medical Device Contract Manufacturing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DRUG DELIVERY DEVICES (Device)
    Forecast Period 2025–2030
    Growth Rate CAGR of 10.9% from 2025 to 2030
    Largest Segment DEVICE DEVELOPMENT & MANUFACTURING SERVICES (Service)
    Market Size Base Year (Billions) ~USD 83.96 (2025)
    Revenue Forecast (Billions) ~USD 140.84 (2030)
    Segments Covered Device, Type, Device Class, Service

    Rest Of Europe Medical Device Contract Manufacturing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Cardiovascular Devices
    • Dental Devices
    • Diabetes Care Devices
    • Diagnostic Imaging Devices
    • Drug Delivery Devices
    • Endoscopy & Laparoscopy Devices
    • Gynecology/ Urology Devices
    • Gynecology/Urology Devices
    • Ivd Devices
    • Neurology Devices
    • Ophthalmology Devices
    • Orthopedic Devices
    • Other Devices
    • Patient Assistive Devices
    • Patient Monitoring Devices
    • Personal Care Devices
    • Respiratory Care Devices
    • Surgical Devices

    By Type

    • Autoinjectors
    • Cardiovascular Devices
    • Dental Devices
    • Device & Component Manufacturing Services
    • Device Engineering Services
    • Diabetes Care Devices
    • Diagnostic Imaging Devices
    • Drug Delivery Devices
    • Endoscopy & Laparoscopy Devices
    • Gynecology/Urology Devices
    • Infusion Devices & Administration Sets
    • Inhalers
    • Inspection & Testing Services
    • Ivd Consumables
    • Ivd Devices
    • Ivd Equipment
    • Labeling Services
    • Neurology Devices
    • Ophthalmology Devices
    • Orthopedic Devices
    • Other Devices
    • Other Drug Delivery Devices
    • Other Packaging & Assembly Services
    • Packaging Validation Services
    • Patient Assistive Devices
    • Patient Monitoring Devices
    • Pen Injectors
    • Personal Care Devices
    • Primary & Secondary Packaging Services
    • Process Development Services
    • Respiratory Care Devices
    • Sterilization Services
    • Surgical Devices
    • Syringes

    By Device Class

    • Class I Medical Devices
    • Class Ii Medical Devices
    • Class Iii Medical Devices

    By Service

    • Device Development & Manufacturing Services
    • Other Services
    • Packaging & Assembly Services
    • Quality Management Services

    Target Audience

    • Medical Device Manufacturers : Evaluate Rest Of Europe as a contract manufacturing destination, comparing regional capabilities, costs, and regulatory compliance to optimize outsourcing strategies and supply chain resilience.
    • Contract Manufacturing Organizations (CMOs/CDMOs) : Assess Rest Of Europe market opportunities, competitive landscape, and growth potential to guide capacity expansion, service line development, and geographic market entry strategies.
    • Private Equity & Investment Firms : Analyze Rest Of Europe's medical device manufacturing sector for acquisition targets, growth investments, and portfolio company expansion opportunities within this 10.3% CAGR growth market.
    • Healthcare Consultants & Advisors : Support client decision-making with comprehensive Rest Of Europe market data, competitive benchmarking, and strategic recommendations for manufacturing partnerships and outsourcing initiatives.
    • Government & Trade Organizations : Monitor Rest Of Europe's medical device manufacturing sector performance, identify policy opportunities, and support regional economic development initiatives in this strategically important healthcare industry.

    Key Companies in the Rest Of Europe Medical Device Contract Manufacturing Market

    CompanyHQOwnershipStrongest segments
    EIKEN CHEMICAL CO., LTD.JapanPublic CompanyFecal immunochemical test (FIT) reagents for colorectal cancer screening,Microbiological reagents (media, antimicrobial susceptibility, rapid tests),Urinalysis test strips (occult blood, protein, glucose),
    CYIENTIndiaPublic CompanyDigital, Engineering & Technology,Design Led Manufacturing,Others (Networks, Operations, and Adjacent Services),
    JABIL INC.United States
    FLEX LTD.SingaporePublic CompanyIntegrated Technology Solutions (ITS),Regulated Manufacturing Solutions (RMS),Cloud and Power Infrastructure (CPI),
    PLEXUS CORP.United StatesPublic CompanyHealthcare/Life Sciences EMS and Design Services,Aerospace/Defense EMS and Engineering,Industrial/Commercial EMS and Sustaining Services,
    SANMINA CORPORATIONUnited StatesPublic CompanyIntegrated Manufacturing Solutions (design-to-delivery EMS),Components, Products and Services,
    INTEGER HOLDINGS CORPORATIONUnited StatesPublic CompanyCardiac Rhythm Management & Heart Failure (devices, leads, power solutions),Neuromodulation (spinal cord stimulators and related components),Cardio & Vascular / Interventional (cardiology, structural heart, peripheral, neurovascular, oncology),
    CELESTICA INC.CanadaPublic CompanyConnectivity and Cloud Solutions,Advanced Technology Solutions,
    WEST PHARMACEUTICAL SERVICES, INC.United StatesPublic CompanyProprietary Products – stoppers, seals, syringe and cartridge components,Proprietary Products – drug containment systems, self-injection devices, and integrated services,Contract-Manufactured Products – devices and assemblies,
    RECIPHARM ABSwedenPrivate CompanyAdvanced Delivery Systems (ADS – inhalation, devices, integrated drug–device),Manufacturing Steriles (MFG-S – injectables, lyophilisation, blow-fill-seal),Manufacturing Solids & Others (MFG-SO – tablets, capsules, semi-solids, liquids, powders),
    KIMBALL ELECTRONICS, INC.United StatesPublic CompanyAutomotive electronics and assemblies,Medical EMS and contract manufacturing (disposables, drug delivery),Industrial and other electronics manufacturing,
    NORTECH SYSTEMS, INC.United StatesPublic CompanyElectromedical devices and imaging assemblies,Electromechanical and industrial systems/box builds,Wire and cable assemblies,
    CARCLO PLCUnited KingdomPublic CompanyIn vitro diagnostics and medical consumables,Drug delivery components and assemblies,Aerospace and safety cables and systems,

    EIKEN CHEMICAL CO., LTD.

    EIKEN CHEMICAL CO., LTD. is a Japanese public company founded in 1939 with 696 employees. The company operates in the chemical manufacturing sector.

    CYIENT

    CYIENT is an Indian public company founded in 1991 with 12,049 employees. The company provides engineering, design, and technology services across multiple industries.

    JABIL INC.

    Insufficient data provided for business description.

    FLEX LTD.

    FLEX LTD. is a Singapore-based public company founded in 1969 with 149,686 employees. The company is a global electronics manufacturing services provider.

    PLEXUS CORP.

    PLEXUS CORP. is a United States-based public company founded in 1979 with 20,000 employees. The company provides electronics manufacturing services and specialized solutions.

    SANMINA CORPORATION

    SANMINA CORPORATION is a United States-based public company founded in 1980 with 35,000 employees. The company is a global provider of electronics manufacturing services and supply chain solutions.

    INTEGER HOLDINGS CORPORATION

    INTEGER HOLDINGS CORPORATION is a United States-based public company founded in 1970 with 11,000 employees. The company manufactures medical devices and components for the healthcare industry.

    CELESTICA INC.

    CELESTICA INC. is a Canadian public company founded in 1994 with 23,803 employees. The company provides electronics manufacturing services and supply chain solutions globally.

    WEST PHARMACEUTICAL SERVICES, INC.

    WEST PHARMACEUTICAL SERVICES, INC. is a United States-based public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for the pharmaceutical and healthcare industries.

    RECIPHARM AB

    RECIPHARM AB is a Swedish private company founded in 1994 with 6,752 employees. The company provides pharmaceutical manufacturing and development services.

    KIMBALL ELECTRONICS, INC.

    KIMBALL ELECTRONICS, INC. is a United States-based public company founded in 1961 with 5,700 employees. The company provides electronics manufacturing services and solutions.

    NORTECH SYSTEMS, INC.

    NORTECH SYSTEMS, INC. is a United States-based public company founded in 1990 with 699 employees. The company provides electronics manufacturing and engineering services.

    CARCLO PLC

    CARCLO PLC is a United Kingdom-based public company founded in 1924 with 907 employees. The company manufactures precision-engineered components and assemblies for various industries.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation metrics for Rest Of Europe ($773.5M in 2025) and forecast projections through 2030, enabling accurate financial planning and investment decisions specific to this regional market.
    • Competitive Positioning Intelligence : Understand Rest Of Europe's 10.3% CAGR relative to global trends (10.9%), identifying regional growth drivers and competitive advantages that differentiate this market from other European and global regions.
    • Regional Market Dynamics : Gain insights into Rest Of Europe's unique regulatory environment, manufacturing capabilities, and market characteristics that influence contract manufacturing demand and supplier selection criteria.
    • Strategic Investment Guidance : Leverage detailed Rest Of Europe market analysis to identify expansion opportunities, partnership potential, and capacity investment priorities aligned with the region's projected $1,262.6M market size by 2030.
    • Customer & Supplier Mapping : Develop targeted go-to-market strategies for Rest Of Europe by understanding regional customer segments, manufacturing specializations, and emerging opportunities in this high-growth outsourcing market.

    Frequently asked questions

    What is the current market size of medical device contract manufacturing in Rest Of Europe?

    Rest Of Europe's medical device contract manufacturing market is valued at $773.5 million in 2025.

    What is the projected market size for Rest Of Europe by 2030?

    Rest Of Europe's medical device contract manufacturing market is projected to reach $1,262.6 million by 2030.

    What is the CAGR for Rest Of Europe's medical device contract manufacturing market?

    Rest Of Europe's medical device contract manufacturing market is expected to grow at a compound annual growth rate of 10.3% from 2025 to 2030.

    Why is Rest Of Europe an attractive location for medical device contract manufacturing?

    Rest Of Europe offers regulatory expertise, advanced manufacturing capabilities, a skilled workforce, established supply chain networks, and proximity to major European markets, making it an ideal destination for contract manufacturing operations.

    What factors are driving growth in Rest Of Europe's medical device contract manufacturing market?

    Growth in Rest Of Europe is driven by increasing outsourcing trends among device manufacturers, rising demand for specialized manufacturing services, regulatory compliance expertise, and expansion of production capacity to serve regional and global markets.

    RESEARCH METHODOLOGY

    The study involved four key activities to estimate the current size of the medical device contract manufacturing market. Extensive secondary research was conducted to gather information on the market, peer markets, and parent market. The next step was to validate these findings, assumptions, and estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to calculate the total market size. Then, market segmentation and data triangulation were applied to determine the size of segments and subsegments.

    Secondary Research

    The secondary research process involved extensively utilizing secondary sources such as directories, databases (like Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. This research was used to gather information essential for the detailed, technical, market-oriented, and commercial analysis of the medical device contract manufacturing market. It also helped obtain critical information about key players, market classification, and segmentation based on industry trends down to the most detailed level, as well as key developments related to market and technology perspectives. Additionally, a database of leading industry players was created using secondary research.

    Primary Research

    During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from several companies and organizations operating in the medical device contract manufacturing market. The primary sources from the demand side consist of industry experts, purchase and sales managers, doctors, and personnel from research organizations. Primary research was carried out to validate the market segmentation, identify key players, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the medical device contract manufacturing market is provided below:

    Medical Device Contract Manufacturing Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the medical device contract manufacturing market includes the following details. The market sizing was undertaken from a global perspective.

    Country-level Analysis: The size of the medical device contract manufacturing market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall medical device contract manufacturing market was obtained from secondary data and validated by primary participants to arrive at the total medical device contract manufacturing market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each stage, assumptions and approaches were verified through industry experts contacted during primary research. Due to limitations in the data available from secondary research, revenue estimates for individual companies (covering the overall medical device contract manufacturing market and regional assessments) were determined based on a detailed analysis of their product offerings, geographic reach or strength (either directly or through distributors or suppliers), and the market shares of leading players in specific regions or countries.

    Medical Device Contract Manufacturing Market

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Medical device contract manufacturing involves a manufacturing company producing medical devices or components that other companies can later sell. These contract manufacturers specialize in specific processes or tasks and provide expertise through their regular manufacturing experience.

    Stakeholders

    • Manufacturers and distributors of medical devices
    • Manufacturers and distributors of medical device components
    • Medical device contract manufacturing companies
    • Healthcare institutes
    • Diagnostic laboratories
    • Hospitals and clinics
    • Academic institutes
    • Research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, segment, and forecast the medical device contract manufacturing market by device, class of device, service, and region
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To strategically analyze the technology analysis, regulatory scenario, value chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, and impact of AI in the medical device contract manufacturing market.
    • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the medical device contract manufacturing market with respect to five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To strategically profile the key players in the medical device contract manufacturing market and comprehensively analyze their core competencies
    • To track and analyze developments such as acquisitions, product/service launches & approvals, expansions, agreements, partnerships, and collaborations reported by leading market players

    Get the Full Medical Device Contract Manufacturing Market Report

    Full forecast, segment splits, and company analysis for all Medical Device Contract Manufacturing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status